Am. J. Respir. Crit. Care Med., Volume 161, Number 1, January 2000, 224-231

Effects of Inhaled Corticosteroid Therapy on Expression and DNA-Binding Activity of Nuclear Factor B in Asthma

LORRAINE HART, SAM LIM, IAN ADCOCK, PETER J. BARNES, and K. FAN CHUNG

Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine and Royal Brompton Hospital, London, United Kingdom

We determined whether inhaled corticosteroid therapy modulates the expression of the transcription factor, nuclear factor kappa B (NF-B), in patients with asthma. Fifteen stable patients with mild asthma underwent bronchoalveolar lavage (BAL) with bronchial biopsies in a double-blind, placebo-controlled and crossover study after placebo or after inhaled fluticasone propionate (500 µg twice daily). Fluticasone reduced the number of eosinophils in BAL fluid (BALF) and in airway biopsies, together with an improvement of bronchial responsiveness to methacholine. However, NF-B DNA-binding in alveolar macrophages and in bronchial biopsies was not affected by fluticasone treatment. NF-B expression was also measured by immunohistochemical staining with an antibody to the p65 component of NF-B. Fluticasone caused an increase in the number of positive nuclear staining cells in the airway epithelium from 34.1 ± 5.0 to 64.1 ± 8.0 per mm² (p = 0.002). In vitro studies of A549 epithelial cells stimulated by interleukin-1 (IL-1) showed that dexamethasone increased p65 protein expression analyzed by Western blot. Despite an anti-inflammatory effect of fluticasone, there was no decrease in NF-B-DNA binding and activation, indicating that this may not be a mechanism by which corticosteroids act in asthma. The significance of corticosteroid-induced increase in p65 protein expression is not known. Hart L, Lim S, Adcock I, Barnes PJ, Chung KF. Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor B in asthma.

This article has been cited by other articles:

				C. Pantano, J. L. Ather, J. F. Alcorn, M. E. Poynter, A. L. Brown, A. S. Guala, S. L. Beuschel, G. B. Allen, L. A. Whittaker, M. Bevelander, et al. Nuclear Factor-{kappa}B Activation in Airway Epithelium Induces Inflammation and Hyperresponsiveness Am. J. Respir. Crit. Care Med., May 1, 2008; 177(9): 959 - 969. [Abstract] [Full Text] [PDF]

				P. J. Barnes Corticosteroid effects on cell signalling Eur. Respir. J., February 1, 2006; 27(2): 413 - 426. [Abstract] [Full Text] [PDF]

				M. J. Walter and M. J. Holtzman A Centennial History of Research on Asthma Pathogenesis Am. J. Respir. Cell Mol. Biol., June 1, 2005; 32(6): 483 - 489. [Full Text] [PDF]

				P. J. Barnes, I. M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur. Respir. J., March 1, 2005; 25(3): 552 - 563. [Abstract] [Full Text] [PDF]

				T. Joseph, D. Look, and T. Ferkol NF-{kappa}B activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa Am J Physiol Lung Cell Mol Physiol, March 1, 2005; 288(3): L471 - L479. [Abstract] [Full Text] [PDF]

				M. A. Campos, M. A. Vargas, V. Regueiro, C. M. Llompart, S. Alberti, and J. A. Bengoechea Capsule Polysaccharide Mediates Bacterial Resistance to Antimicrobial Peptides Infect. Immun., December 1, 2004; 72(12): 7107 - 7114. [Abstract] [Full Text] [PDF]

				M. E. Poynter, R. Cloots, T. van Woerkom, K. J. Butnor, P. Vacek, D. J. Taatjes, C. G. Irvin, and Y. M. W. Janssen-Heininger NF-{kappa}B Activation in Airways Modulates Allergic Inflammation but Not Hyperresponsiveness J. Immunol., December 1, 2004; 173(11): 7003 - 7009. [Abstract] [Full Text] [PDF]

				R. P. Schleimer Glucocorticoids Suppress Inflammation but Spare Innate Immune Responses in Airway Epithelium Proceedings of the ATS, November 1, 2004; 1(3): 222 - 230. [Abstract] [Full Text] [PDF]

				B. G. Cosio, B. Mann, K. Ito, E. Jazrawi, P. J. Barnes, K. F. Chung, and I. M. Adcock Histone Acetylase and Deacetylase Activity in Alveolar Macrophages and Blood Mononocytes in Asthma Am. J. Respir. Crit. Care Med., July 15, 2004; 170(2): 141 - 147. [Abstract] [Full Text] [PDF]

				M. Castro, S. R. Bloch, M. V. Jenkerson, S. DeMartino, D. L. Hamilos, R. B. Cochran, X. E. L. Zhang, H. Wang, J. P. Bradley, K. B. Schechtman, et al. Asthma Exacerbations after Glucocorticoid Withdrawal Reflects T Cell Recruitment to the Airway Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 842 - 849. [Abstract] [Full Text] [PDF]

				A. KUMAR, S. LNU, R. MALYA, D. BARRON, J. MOORE, D. B. CORRY, and A. M. BORIEK Mechanical stretch activates nuclear factor-kappaB, activator protein-1, and mitogen-activated protein kinases in lung parenchyma: implications in asthma FASEB J, October 1, 2003; 17(13): 1800 - 1811. [Abstract] [Full Text] [PDF]

				P. J. Barnes and I. M. Adcock How Do Corticosteroids Work in Asthma? Ann Intern Med, September 2, 2003; 139(5_Part_1): 359 - 370. [Full Text] [PDF]

				M. E. Poynter, C. G. Irvin, and Y. M. W. Janssen-Heininger A Prominent Role for Airway Epithelial NF-{kappa}B Activation in Lipopolysaccharide-Induced Airway Inflammation J. Immunol., June 15, 2003; 170(12): 6257 - 6265. [Abstract] [Full Text] [PDF]

				S. Escotte, O. Tabary, D. Dusser, C. Majer-Teboul, E. Puchelle, and J. Jacquot Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-{beta} kinase pathway Eur. Respir. J., April 1, 2003; 21(4): 574 - 581. [Abstract] [Full Text] [PDF]

				K. Tomita, G. Caramori, S. Lim, K. Ito, T. Hanazawa, T. Oates, I. Chiselita, E. Jazrawi, K. F. Chung, P. J. Barnes, et al. Increased p21CIP1/WAF1 and B Cell Lymphoma Leukemia-xL Expression and Reduced Apoptosis in Alveolar Macrophages from Smokers Am. J. Respir. Crit. Care Med., September 1, 2002; 166(5): 724 - 731. [Abstract] [Full Text] [PDF]

				S L Traves, S V Culpitt, R E K Russell, P J Barnes, and L E Donnelly Increased levels of the chemokines GRO{alpha} and MCP-1 in sputum samples from patients with COPD Thorax, July 1, 2002; 57(7): 590 - 595. [Abstract] [Full Text] [PDF]

				D.-w. Jeong, M.-H. Yoo, T. S. Kim, J.-H. Kim, and I. Y. Kim Protection of Mice from Allergen-induced Asthma by Selenite. PREVENTION OF EOSINOPHIL INFILTRATION BY INHIBITION OF NF-kappa B ACTIVATION J. Biol. Chem., May 10, 2002; 277(20): 17871 - 17876. [Abstract] [Full Text] [PDF]

				W. Y. Almawi and O. K. Melemedjian Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor J. Leukoc. Biol., January 1, 2002; 71(1): 9 - 15. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Asthma, Airway Biology, and Allergic Rhinitis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1559 - 1580. [Full Text] [PDF]

				E. Cazes, J. Giron-Michel, S. Baouz, C. Doucet, F. Cagnoni, S. Oddera, M. Korner, G. Dasic, R. Testi, B. Azzarone, et al. Novel Anti-inflammatory Effects of the Inhaled Corticosteroid Fluticasone Propionate During Lung Myofibroblastic Differentiation J. Immunol., November 1, 2001; 167(9): 5329 - 5337. [Abstract] [Full Text] [PDF]

				S. J. WILSON, A. WALLIN, G. DELLA-CIOPPA, T. SANDSTROM, and S. T. HOLGATE Effects of Budesonide and Formoterol on NF-kappa B, Adhesion Molecules, and Cytokines in Asthma Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1047 - 1052. [Abstract] [Full Text] [PDF]

				P. J. Smith, D. J. Cousins, Y.-K. Jee, D. Z. Staynov, T. H. Lee, and P. Lavender Suppression of Granulocyte-Macrophage Colony-Stimulating Factor Expression by Glucocorticoids Involves Inhibition of Enhancer Function by the Glucocorticoid Receptor Binding to Composite NF-AT/Activator Protein-1 Elements J. Immunol., September 1, 2001; 167(5): 2502 - 2510. [Abstract] [Full Text] [PDF]

				A. J. Edgar, E. J. Birks, M. H. Yacoub, and J. M. Polak Cloning of Dexamethasone-Induced Transcript . A Novel Glucocorticoid-Induced Gene that Is Upregulated in Emphysema Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 119 - 124. [Abstract] [Full Text] [PDF]